Skip to main content
. Author manuscript; available in PMC: 2019 Dec 9.
Published in final edited form as: J Clin Pathol. 2018 Sep 18;71(12):1108–1115. doi: 10.1136/jclinpath-2018-205396

Figure 4. Case Example.

Figure 4.

PET CT and T1-weighted MRI of the brain at A) presentation, B) after 7 weeks of crizotinib, and C) 8 months after starting crizotinib. Patient was discovered to have a MET exon 14 deletion using the Solid Tumor Focus Assay and clinical management and outcome was changed based on this result.